Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Anne W S Rutjes, Ettore Porreca, Marcello Di Nisio & Hans-Martin Otten
BACKGROUND Venous thromboembolism (VTE) often complicates the clinical course of cancer. The risk is further increased by chemotherapy, but the safety and efficacy of primary thromboprophylaxis in cancer patients treated with chemotherapy is uncertain. This is an update of a review first published in February 2012. OBJECTIVES To assess the efficacy and safety of primary thromboprophylaxis for VTE in ambulatory cancer patients receiving chemotherapy compared with placebo or no thromboprophylaxis. SEARCH METHODS For this update,...
This data center is not currently reporting usage information. For information on how your repository can submit usage information, please see our Documentation.